NCT Number: NCT06947122
The goal of this clinical trial is to evaluate whether a smartphone app-based ecological momentary intervention called Mindful Journey, which teaches mindfulness skills, can support adults in recovery from both opioid use disorder and chronic pain. The primary objective of this pilot study is to assess the feasibility and acceptability of Mindful Journey in this population.
Interested in participating?
Request Info18 year and older
All sexes
Interventional
Not applicable
Arizona State University, Phoenix, Arizona, United States
There is a paucity of interventions for co-occurring opioid use disorder and chronic pain. Difficulty with emotion regulation is a key shared vulnerability factor underlying both conditions. Mindfulness-Based Interventions (MBIs) are a promising intervention approach, as they target core skills that can improve emotion regulation. However, research on MBIs for co-morbid opioid use disorder and chronic pain is limited. Existing MBIs are also limited by not providing adequate support "in the moment" when individuals are in high-risk situations. A responsive, momentary MBI for co-occurring opioid use disorder and chronic pain may be highly promising, but has yet to be established. In the present study, we will be evaluating a smartphone app-based ecological momentary intervention, called Mindful Journey, for individuals with opioid use disorder and chronic pain. The core feature of the app is training in mindful acceptance and savoring skills via momentary "just-in-time" delivery of brief video-based exercises based upon ecological momentary assessments.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
The Mindful Journey intervention includes (1) 14 foundational modules/lessons, (2) brief check-in surveys (3 times/day) via the app, (3) app-guided momentary mindfulness coaching (max 3 times/day), and (4) brief phone-based check-in from a trained staff member, on a weekly basis. Occurring for approximately 8 weeks following enrollment visit
Other names: Mindful Journey
Time frame: Assessed at the end of the 8-week treatment period
Single-items measuring ratings of acceptability dimensions for the lessons, including usability, understandability, engage-ability, visual appeal, helpfulness, skill acquisition, and confidence implementing skills. Scores for each item range from 1 to 5, with higher scores indicating better acceptability.
Time frame: Assessed at the end of the 8-week treatment period
Single-items measuring ratings of acceptability dimensions for ecological momentary intervention (momentary coaching), including usability, understandability, engage-ability, visual appeal, helpfulness, skill acquisition, and confidence implementing skills. Scores for each item range from 1 to 5, with higher scores indicating better acceptability.
Time frame: Administered immediately after participants receive each ecological momentary intervention (momentary coaching)
Single item of perceived helpfulness
Time frame: 8-week treatment period
Percent of lessons completed
Time frame: 8-week treatment period
Percent of ecological momentary interventions (momentary coaching) completed
Time frame: 8-week treatment period
Percent of momentary check-in surveys completed
Contact information is provided by the study sponsor or research team.
Chung Jung Mun, Ph.D
CONTACT
Corey Roos, Ph.D
CONTACT
Arizona State University
Other
Mindfulness-Based Ecological Momentary Intervention for Co-Occurring Opioid Use Disorder and Chronic Pain: A Pilot Study
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06544291
Chemically-Induced Disorders, Chronic Pain
New Haven, Connecticut, United States
View Trial DetailsNCT04587791
Chemically-Induced Disorders, Chronic Pain
West Haven, Connecticut, United States
View Trial DetailsNCT05492825
Back Pain Lower Back Chronic, Chemically-Induced Disorders
The Bronx, New York, United States
View Trial DetailsNCT05459402
Chemically-Induced Disorders, Chronic Pain
Baltimore, Maryland, United States
View Trial Details